• Hemispherx News 04

Prostate Cancer News Today Provides an Ampligen Upate

July 9th, 2019|

Prostate Cancer News Today Provides an Ampligen Update We recently announced that the Roswell Park Comprehensive Cancer Center had received FDA authorization to proceed with its Phase 2 study using our lead [...]

  • Hemispherx News 02

CEO Roadshow Interviews Hemispherx Thomas K. Equels

April 4th, 2019|

CEO Roadshow Interviews Hemispherx Thomas K. Equels Hemispherx CEO Thomas K. Equels recently sat down with Mike Elliot of CEO Roadshow to provide an update on everything the company is working at [...]

  • Hemispherx News 04

Introducing You to the First Ampligen Quarterly Update

March 25th, 2019|

Introducing You to the First Ampligen Quarterly Update Today we announced significant progress in our Ampligen pancreatic cancer program and our multiple Ampligen plus checkpoint blockade immuno-oncology programs. We also announced the [...]

SHOW ALL